Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Richard J Daly is Director at Aquestive Therapeutics. OQRO lists 3 transactions filed with the SEC under this name, the latest on Nov 12, 2026, each linked to the official Form 4.
Director
Disclosures on record
3
Companies involved
1
Richard J Daly bought shares on the open market in 2016, 2017 and 2026 across 2 companies.
Richard J Daly reported 9 open-market purchases and 0 sales since 2016; purchases in 3 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $99K2×2 trades | — |
| 2017 | $50K3×3 trades | — |
| 2016 | $40K4×4 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
1 purchase disclosed. $1,000 placed after each of the 1 purchases disclosed since 2025-11-14 would be worth $1K today ($1K put in); the same in the S&P 500 (SPY): $1K.
Not ranked: fewer than 10 purchases measured at 90 days. The middle of the 82 ranked insiders is −5.5 pts (median, against the S&P 500).
Equal weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
Aquestive TherapeuticsAQST
3 disclosures · Nov 2026 · 2 bought
Nov 10, 2026Bought~$95Kdisclosed Nov 12
DetailsOfficial recordNov 10, 2026Bought~$4.2Kdisclosed Nov 12
DetailsOfficial recordNov 6, 202657Kdisclosed Nov 10
DetailsOfficial recordAs of the latest filing on , Richard J Daly reported holding 28,025 shares of Aquestive Therapeutics (AQST), worth about $110K at the last close of $4 (Nov 13, 2026). In the last 12 months, Richard J Daly bought $99K in 2 open-market purchases.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Aquestive Therapeutics AQST | 28,025 | 28K direct | $4 | $110K | Nov 10, 2026 |
Is this Richard J Daly’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Nov 10, 2026, Richard J Daly reported holding 28,025 shares of Aquestive Therapeutics (AQST). At the last close of $4 on Nov 13, 2026, that is about $110K. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Richard J Daly reported 2 open-market purchases worth $99K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Richard J Daly bought shares on the open market in 2016, 2017 and 2026 across 2 companies.
In SEC filings since 2016: the latest open-market purchase is from 2026; no open-market sale is on record.
2 companies: Aquestive Therapeutics (AQST, 2026), Palisade Bio (PALI, 2016–2017).
Richard J Daly reported 7 open-market purchases and 0 sales here, 2016 to 2017.
Richard J Daly reported 2 open-market purchases and 0 sales here, 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
